# Achieve Life Sciences, Inc.: Form SCHEDULE 13D, filed Apr 24, 2026

- Company: [Achieve Life Sciences, Inc.](/companies/achv.md) (CIK 949858)
- Form: SCHEDULE 13D
- Filed: 2026-04-24
- Accepted by EDGAR: Apr 24, 2026, 17:03 ET
- Period: not reported
- Accession: 0001999371-26-009036
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/949858/000199937126009036/xslSCHEDULE_13D_X02/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/949858/000199937126009036/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/949858/000199937126009036/xslSCHEDULE_13D_X02/primary_doc.xml

Filed Apr 24, 2026.
Source: SEC EDGAR, the filing index for accession 0001999371-26-009036. Last ingested by Listed: Nov 11, 2026, 00:38 ET. No prices; not investment advice.
